Global Pharmaceutical Packaging Demand to Grow 6.0% Annually Through 2021
February 6, 2018 (Investorideas.com Newswire) Global pharmaceutical packaging demand is projected to advance 6.0% per year to $112 billion in 2021. Aging populations, rising levels of acute and chronic conditions, and new product introductions will drive demand. These and other trends are presented in Global Pharmaceutical Packaging, 12th Edition, a new study from The Freedonia Group, a Cleveland-based industry research firm.
Prefillable syringes will post the fastest gains of any pharmaceutical container, increasing 9.0% per year through 2021. Demand will be supported by expanding applications in the administration of critical care, emergency, and self-injectable parenteral medication. Advances in biotechnology, nanotechnology, and other advanced drug delivery technologies will increase the range of pharmaceuticals adaptable to this packaging.
Western Europe will continue to make up the greatest share of pharmaceutical packaging demand. Demand is spurred by the region's large, advanced drug-producing industry that develops new packaging systems and introduces sophisticated therapies with specialized packaging needs.
Global Pharmaceutical Packaging, 12th Edition (published 1/2018, 345 pages) is available for $6700 from The Freedonia Group. For further details or to arrange an interview with the analyst, please contact Corinne Gangloff by phone 440.684.9600 or email email@example.com.
Related studies include:
- #3538 Global Caps & Closures Market, 9th Edition (September 2017)
- #3529 Packaging Films Market in the US (July 2017)
About The Freedonia Group, a division of MarketResearch.com - The Freedonia Group is a leading international industrial research company publishing more than 100 studies annually. Since 1985, we have provided research to customers ranging in size from global conglomerates to one-person consulting firms. More than 90% of the industrial companies in the Fortune 500 use Freedonia Group research to help with their strategic planning. Additional Packaging studies can be purchased at www.freedoniagroup.com, www.marketresearch.com and www.profound.com.
This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release on the Investorideas.com newswire http://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.